Renin–Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study

BACKGROUND: Angiotensin‐converting enzyme inhibitors (ACE‐Is) and angiotensin receptor blockers (ARBs) may worsen the prognosis of coronavirus disease 2019, but any association could be confounded by the cardiometabolic conditions indicating ACE‐I/ARB use. We therefore examined the impact of ACE‐Is/...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiansen, Christian Fynbo, Heide‐Jørgensen, Uffe, Rasmussen, Thomas Bøjer, Bodilsen, Jacob, Søgaard, Ole Schmeltz, Maeng, Michael, Vistisen, Simon Tilma, Schmidt, Morten, Pottegård, Anton, Lund, Lars Christian, Reilev, Mette, Hallas, Jesper, Johansen, Nanna Borup, Brun, Nikolai Constantin, Sørensen, Henrik Toft, Thomsen, Reimar Wernich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792378/
https://www.ncbi.nlm.nih.gov/pubmed/32998607
http://dx.doi.org/10.1161/JAHA.120.017297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792378/
https://www.ncbi.nlm.nih.gov/pubmed/32998607
http://dx.doi.org/10.1161/JAHA.120.017297

Ejemplares similares